Evidence map›Paper›PMID 25352942›Full record

ArticleBiomicrofluidics2014

A three dimensional thermoplastic microfluidic chip for robust cell capture and high resolution imaging.

Guillaume Mottet, Karla Perez-Toralla, Ezgi Tulukcuoglu, Francois-Clement Bidard, Jean-Yves Pierga, Irena Draskovic, Arturo Londono-Vallejo, Stephanie Descroix, Laurent Malaquin, Jean Louis Viovy

Abstract read
In one paragraph

Article in Biomicrofluidics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Biomedical Application of Functional Materials in Organ-on-a-Chip.Frontiers in bioengineering and biotechnology · 2020
    Review
  9. Rapid micro fluorescenceBiomicrofluidics · 2018
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Guillaume MottetInstitut Curie, UMR 168 , 11 rue Pierre et Marie Curie, 75005 Paris, France.
Karla Perez-TorallaInstitut Curie, UMR 168 , 11 rue Pierre et Marie Curie, 75005 Paris, France.
Ezgi TulukcuogluInstitut Curie, UMR 168 , 11 rue Pierre et Marie Curie, 75005 Paris, France.
Francois-Clement BidardDepartment of Medical Oncology, Institut Curie , Paris, France.
Jean-Yves Pierga
Irena DraskovicTelomeres and Cancer Laboratory, Institut Curie, UPMC Univ. Paris 06 , Equipe Labellisé « Ligue », Paris, France.
Arturo Londono-VallejoTelomeres and Cancer Laboratory, Institut Curie, UPMC Univ. Paris 06 , Equipe Labellisé « Ligue », Paris, France.
Stephanie DescroixInstitut Curie, UMR 168 , 11 rue Pierre et Marie Curie, 75005 Paris, France.
Laurent MalaquinInstitut Curie, UMR 168 , 11 rue Pierre et Marie Curie, 75005 Paris, France.
Jean Louis ViovyInstitut Curie, UMR 168 , 11 rue Pierre et Marie Curie, 75005 Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a low cost microfluidic chip integrating 3D micro-chambers for the capture and the analysis of cells. This device has a simple design and a small footprint. It allows the implementation of standard biological protocols in a chip format with low volume consumption. The manufacturing process relies on hot-embossing of cyclo olefin copolymer, allowing the development of a low cost and robust device. A 3D design of microchannels was used to induce high flow velocity contrasts in the device and provide a selective immobilization. In narrow distribution channels, the liquid velocity induces a shear stress that overcomes adhesion forces and prevents cell immobilization or clogging. In large 3D chambers, the liquid velocity drops down below the threshold for cell attachment. The devices can be operated in a large range of input pressures and can even be handled manually using simple syringe or micropipette. Even at high flow injection rates, the 3D structures protect the captured cell from shear stress. To validate the performances of our device, we implemented immuno-fluorescence labeling and Fluorescence in Situ Hybridization (FISH) analysis on cancer cell lines and on a patient pleural effusion sample. FISH is a Food and Drug Administration approved cancer diagnostic technique that provides quantitative information about gene and chromosome aberration at the single cell level. It is usually considered as a long and fastidious test in medical diagnosis. This process can be easily implanted in our platform, and high resolution fluorescence imaging can be performed with reduced time and computer intensiveness. These results demonstrate the potential of this chip as a low cost, robust, and versatile tool adapted to complex and demanding protocols for medical diagnosis.

Identifiers

PMID25352942
PMCPMC4209894

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.